What is
DUROLANE?

DUROLANE is a unique, single-injection hyaluronic acid therapy that provides long-lasting pain relief from osteoarthritis, for up to 6 months.2

What makes DUROLANE different is its hyaluronic acid formulation, which has been carefully stabilized to resist degradation, extending the time DUROLANE stays in the joint and adding to its long-lasting effect.1,26,29

As the chosen therapy of over 2 million osteoarthritis patients worldwide,27 it is clinically proven safe for repeated courses of therapy,2 and provides longer-lasting pain relief versus a steroid injection2 or Synvisc-One®.*4

Beyond safe pain relief, DUROLANE may help delay knee replacement surgery.**9, 10

*Some patients were treated with a three-injection Synvisc® regimen. A three-injection Synvisc regimen is equivalent to one injection of Synvisc-One.

**While not specifically studied in Altman et al. analysis,3 DUROLANE belongs to the hyaluronic acid class of treatments, and has been found in two other studies to perform similarly to the hyaluronic acid brands that were analysed in the Altman study. These studies are DUROLANE vs. Synvisc/Synvisc-One, McGrath et al.;4 and DUROLANE vs. SUPARTZ: Zhang et al.28

Learn more about DUROLANE and how it works

14 Whatisdurolane_Middle_Section

Choosing DUROLANE means less time seeking pain relief and more time doing what you love.

Summary of Indications for Use

DUROLANE (3 mL): Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

DUROLANE SJ (1 mL): Symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, and toes.

Both DUROLANE and DUROLANE SJ are also indicated for pain following joint arthroscopy in the presence of osteoarthritis within three months of the procedure.

You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children.

Risks can include transient pain, swelling and/or stiffness at the injection site.

Full prescribing information can be found in product labeling (1 mL / 3 mL).